91 related articles for article (PubMed ID: 22285491)
1. RUVBL2 is a novel repressor of ARF transcription.
Xie C; Wang W; Yang F; Wu M; Mei Y
FEBS Lett; 2012 Feb; 586(4):435-41. PubMed ID: 22285491
[TBL] [Abstract][Full Text] [Related]
2. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
3. MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells.
Martin V; Jørgensen HF; Chaubert AS; Berger J; Barr H; Shaw P; Bird A; Chaubert P
Pathobiology; 2008; 75(5):281-7. PubMed ID: 18931530
[TBL] [Abstract][Full Text] [Related]
4. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
5. Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control.
Hasan MK; Yaguchi T; Minoda Y; Hirano T; Taira K; Wadhwa R; Kaul SC
Biochem J; 2004 Jun; 380(Pt 3):605-10. PubMed ID: 15109303
[TBL] [Abstract][Full Text] [Related]
6. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
7. ATM activity contributes to the tumor-suppressing functions of p14ARF.
Li Y; Wu D; Chen B; Ingram A; He L; Liu L; Zhu D; Kapoor A; Tang D
Oncogene; 2004 Sep; 23(44):7355-65. PubMed ID: 15258567
[TBL] [Abstract][Full Text] [Related]
8. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
9. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.
Suzuki H; Kurita M; Mizumoto K; Moriyama M; Aiso S; Nishimoto I; Matsuoka M
Biochem Biophys Res Commun; 2005 Jan; 326(1):242-8. PubMed ID: 15567177
[TBL] [Abstract][Full Text] [Related]
10. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene.
Ameyar-Zazoua M; Wisniewska MB; Bakiri L; Wagner EF; Yaniv M; Weitzman JB
Oncogene; 2005 Mar; 24(14):2298-306. PubMed ID: 15688012
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of chicken p15INK4b at senescence and in the developing brain.
Kim SH; Rowe J; Fujii H; Jones R; Schmierer B; Kong BW; Kuchler K; Foster D; Ish-Horowicz D; Peters G
J Cell Sci; 2006 Jun; 119(Pt 12):2435-43. PubMed ID: 16720639
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
13. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
14. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
Russell JL; Weaks RL; Berton TR; Johnson DG
Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
16. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
17. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
18. Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells.
Diaz-Rodriguez E; García-Lavandeira M; Perez-Romero S; Senra A; Cañibano C; Palmero I; Borrello MG; Dieguez C; Alvarez CV
Oncogene; 2012 Jun; 31(23):2824-35. PubMed ID: 22020338
[TBL] [Abstract][Full Text] [Related]
19. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
Gilley J; Fried M
Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
[TBL] [Abstract][Full Text] [Related]
20. CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus.
Rodriguez C; Borgel J; Court F; Cathala G; Forné T; Piette J
Biochem Biophys Res Commun; 2010 Feb; 392(2):129-34. PubMed ID: 20051228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
